3200威尼斯vip(中国)有限公司

News
NEWS
Home News Company News
Another Victory | Suzhou CellPro Biotechnology Co., Ltd. Recognized as a Potential Unicorn Enterprise in Jiangsu Province!
2022-12-21

On December 9, the 2022 Jiangsu Province Unicorn, Potential Unicorn, and Gazelle Enterprise Evaluation Results were released, and Suzhou CellPro Biotechnology Co., Ltd. was rated as[2022 Jiangsu Province Potential Unicorn Enterprise]。



In recent years, "unicorn" has become synonymous with innovative development and a benchmark for technology-based enterprises.As the reserve force of unicorn enterprises, "potential unicorns" are tomorrow's stars with greater development potential and growth prospects.


At the same time, the life sciences industry is experiencing explosive growth and gradually becoming a new driving force for economic development. As an emerging high-end biomedical consumables company, CellPro Biology's selection as a provincial "potential unicorn" in just a few short years is sufficient proof of its outstanding strength and enormous potential.



Since its establishment,CellPro Biotech has always adhered to innovative R&D and technology leadership, starting from the core needs of life science solutions., continuously improving the product matrix to achieve full-process customized product development of biomedical consumables with leading engineering R&D and manufacturing capabilities, to a strong quality control system and biological validation capabilities, and then to mature production processes, able to meet customers' global and large-scale market demands.



In addition to R&D and innovation, Sepu Biotech's performance in production capacity is equally impressive.The company has established 4 production bases in Suzhou, China, Nantong, China, and Abu Dhabi, UAE, with over 100 fully automated production lines.


Independent automation equipment development team and comprehensive technical capabilities in injection molding, extrusion, and blow molding, assisting enterprises in building automated manufacturing systems, achieving automated and digital production, with overall production capacity growing exponentially. ---



With reliable products and high-quality services,CellPro Biology has been favored by a vast number of customers for many years and has passed rigorous testing by authoritative certification bodies in many countries around the world., has obtained CE-MDR, FDA, ISO13485, ISO9001, and ISO14001 certifications, and its products are exported to five continents, covering more than 50 countries and regions.


Cybio Quality Control and Application Validation Platform hasGene amplification laboratory, cell culture laboratory, microbiology laboratory, automation workstation adaptation laboratoryetc., enabling one-stop biological performance validation and integrated R&D of consumables, reagents, and instruments.


EspeciallyLiquid handling consumables and cell culture consumablesIn terms of aspects, the product has undergone iterative upgrades, providing users with a more outstanding product lineup.



Not yetCome on, Sepsan.Objects and generalsContinuing to uphold the corporate development strategy of technological innovation as the core, rooted in China and oriented toward the world, we will further accelerate the innovative development and commercial application of products, and continuously provide the world with higher-quality advanced medical consumable products.

Share to:
Products
Cell Biology
Molecular Biology
Liquid Handling
Bioprocessing
Custom Products
Solutions
Biopharmaceuticals
Cell & Gene Therapy
Vaccines
Diagnostics & Testing
About Us
Company Profile
Corporate Culture
Development History
Honors & Qualifications
Contact Us
Service Hotline: 400-800-6815
Email: info@cellprobio.net
Address: Building 40, No. 18 Dongchang Road, Suzhou Industrial Park
[WeChat Account QR Code]
Copyright © 2023 Suzhou CellPro Biotechnology Co., Ltd. All rights reserved. Record No.:Su ICP No. 19059453-1
Baidu
sogou